Table 1 |
||||
| Number of events and sample size according to potential efficacy rates in both arms | ||||
| HIV transmission in 3TC arm | ||||
| 0.03 | 0.04 | 0.05 | ||
| HIV transmission in LPV/r arm | 0.01 | 1428 subjects | 682 subjects | 430 subjects |
| 27 events | 16 events | 12 events | ||
| 0.015 | 3190 subjects | 1223 subjects | 704 subjects | |
| 67 events | 32 events | 22 events | ||
| 0.02 | 2204 subjects | 1118 subjects | ||
| 63 events | 37 events | |||
| 0.025 | 1800 subjects | |||
| 64 events | ||||
Nagot et al. BMC Infectious Diseases 2012 12:246 doi:10.1186/1471-2334-12-246